📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
AUROBINDO PHARMA LTD.AUROPHARMAPharmaceuticals
Open
1308
High
1319.8
Low
1289.4
Close
1311.9
Volume
2110239
Exchange
nse
Time
12-Mar-2026

Outlook

Score:

4.5

Rating:

FAIR

Candlestick Pattern

CandlepatternofAurobindoPharmais
High Wave
EstimatedStoplossofAurobindoPharmais
1289.4
AurobindoPharmahasa
Bullishℹ
pattern.
Formationof
High Wave
candlepatternindicatesthetrenddirectionofAurobindoPharmais
Unpredictableℹ
.

Trend

AurobindoPharmaisin
Sideways trendℹ
.
PriceofAurobindoPharmais
Upℹ
by

9.66

%.
Target
Buy@

1113.26

Sell@

1271.44

Current@

1311.9

Volume

ThetradevolumeofAurobindoPharmahasbeen
Goodℹ
ThoughthevolumetrendforAurobindoPharmaappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofAurobindoPharmais

Up

by

40.25

%

Valuation

ThecurrentmarketpriceofAurobindoPharmais
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth49784crandtotalassetsworth49784cr,thebalancesheetofAurobindoPharmais:
Balancedℹ
.
Cashflow
AurobindoPharmahas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 2178cr

.Itis
Upℹ
by

316.5

%.
66.21% i.e. ₹ 3924cr earned in operatingℹ
31.63% i.e. ₹ 1875cr spent in investingℹ
2.01% i.e. ₹ 119cr earned in financingℹ
0.15% i.e. ₹ 9cr earned in otherℹ
AurobindoPharmahas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 1006cr

.Itis
Downℹ
by

539.3

%.
32.44% i.e. ₹ 2434cr earned in operatingℹ
56.71% i.e. ₹ 4255cr spent in investingℹ
10.66% i.e. ₹ 800cr earned in financingℹ
0.19% i.e. ₹ 14cr earned in otherℹ
Income
TheincomeofAurobindoPharmais

₹ 8406cr

and

Profit

is:

₹ 846cr

AurobindoPharmaProfitisupby:

2.92

%andIncomeisUpby:

5.43

%
TheincomeofAurobindoPharmais

₹ 7973cr

and

Profit

is:

₹ 822cr

AurobindoPharmaProfitisdownby:

12.09

%andIncomeisDownby:

6.38

%
TheincomeofAurobindoPharmais

₹ 8516cr

and

Profit

is:

₹ 935cr

AurobindoPharmaProfitisupby:

10.91

%andIncomeisUpby:

4.68

%
By using this site you agree to the use of cookies to deliver a better site experience.